We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RAN Biotechnologies Announces Distributorship Agreement with Fluigent

News   Jul 16, 2014

 
RAN Biotechnologies Announces Distributorship Agreement with Fluigent
 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

How Does DEET Keep Mosquitoes at Bay?

News

Since its invention during WWII, researchers have been trying to pinpoint precisely how DEET actually affects mosquitos. New research suggests DEET may chemically “cloak” humans from malaria-carrying mosquitos, rather than repel them.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE